Abstract
In a case of 46-year-old woman suffering from schizophrenia for over 20 years, she experienced frequent episodes of dyspnea and confirmed as superimposed with myasthenia gravis (MG). Throughout the seven-year follow-up period, after diagnosed as MG, she has been hospitalized 6 times and also diagnosed as colorectal cancer. Authors experienced various conditions associated with untoward effects of medication for myasthenia, schizophrenia, and colorectal cancer. Therefore, authors reported considerations for the pharmacotherapy of schizophrenia with myasthenia gravis.
| Original language | English |
|---|---|
| Pages (from-to) | 300-302 |
| Number of pages | 3 |
| Journal | Psychiatry Investigation |
| Volume | 10 |
| Issue number | 3 |
| DOIs | |
| Publication status | Published - Sept 2013 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Cancer
- Dyspnea
- Myasthenia gravis
- Schizophrenia
- Steroid
Fingerprint
Dive into the research topics of 'Myasthenia gravis, schizophrenia, and colorectal cancer in a patient: Long-term follow-up with medication complexity'. Together they form a unique fingerprint.Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver